糖尿病改变血清镁与动脉钙化及僵硬度的关联:新发透析患者分析
该研究对367例新发血液透析患者进行横断面分析,检验血清镁浓度与动脉钙化及僵硬度的关联是否受糖尿病影响。结果显示,非糖尿病患者中较高血镁与较低冠状动脉钙化、胸主动脉钙化及高踝臂指数风险相关;糖尿病患者中较高血镁仅与胸主动脉钙化风险升高相关,镁与脉搏波速度及脉压无关。
要点
- 非糖尿病透析患者中,血镁每升高0.1 mEq/l与冠状动脉钙化评分非零风险降低15.4%相关。
- 非糖尿病透析患者中,血镁升高与胸主动脉钙化及高踝臂指数风险降低相关。
- 糖尿病透析患者中,血镁升高与胸主动脉钙化风险升高相关,与冠脉钙化及高踝臂指数无关。
核心结论
- 糖尿病改变了血清镁与新发血液透析患者动脉钙化及僵硬度的关联。
- 非糖尿病患者中较高血镁与较少动脉钙化和较低外周动脉僵硬度相关。
- 糖尿病患者中较高血镁仅与胸主动脉钙化评分大于0的几率升高相关。
研究设计与样本
- 研究为横断面分析,纳入PACE队列中367例新发血液透析患者。
- 平均血清镁为1.8±0.2 mEq/l,58%的患者患有糖尿病。
- 评估指标包括冠状动脉钙化评分、胸主动脉钙化评分、踝臂指数、脉搏波速度和脉压。
主要发现
- 非糖尿病患者中,血镁每升高0.1 mEq/l,冠状动脉钙化评分非零的差异为-15.4%(95%CI -28%至-0.55%,P=0.03)。
- 非糖尿病患者中,血镁每升高0.1 mEq/l,胸主动脉钙化评分大于0的OR为0.66(95%CI 0.47-0.93,P=0.02),高踝臂指数的OR为0.23(95%CI 0.06-0.83,P=0.03)。
- 糖尿病患者中,血镁每升高0.1 mEq/l,胸主动脉钙化评分大于0的OR为1.57(95%CI 1.09-2.26,P=0.02)。
- 糖尿病患者中,血镁与冠状动脉钙化或高踝臂指数无显著关联。
- 无论糖尿病状态如何,血镁与脉搏波速度或脉压均无显著关联。
临床怎么用
- 在解读透析患者血镁与血管钙化风险时,应区分糖尿病状态。
- 非糖尿病透析患者中较高血镁可能提示较低的动脉钙化及外周僵硬度风险。
- 糖尿病透析患者中较高血镁与胸主动脉钙化风险升高相关,需谨慎解读。
局限性
- 研究为横断面设计,无法推断因果关系。
- 样本来自单一队列,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Magnesium (Mg) may protect against arterial calcification. We tested the hypotheses that a higher serum Mg concentration is associated with less arterial calcification and stiffness in patients on hemodialysis (HD) and that these associations are modified by diabetes mellitus. METHODS: We performed cross-sectional analyses of 367 incident HD patients from the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) cohort. Measures of arterial calcification and stiffness included coronary arterial calcification (CAC) and thoracic aortic calcification (TAC) scores, ankle brachial index (ABI; high ABI: >1.4 or incompressible vessels), pulse wave velocity (PWV), and pulse pressure. RESULTS: Mean Mg was 1.8 ± 0.2 mEq/l and 58% had diabetes. Among nondiabetic individuals, per 0.1 mEq/l higher Mg, non-zero CAC score was lower (% difference: -15.4%; 95% confidence interval [CI]: -28% to -0.55%; P = 0.03), the odds of having TAC score >0 and the odds of having high ABI were lower (odds ratio [OR]: 0.66; 95% CI 0.47-0.93; P = 0.02, and 0.23; 95% CI: 0.06-0.83, P = 0.03, respectively) while adjusting for demographics, comorbidities, markers of mineral metabolism, and dialysis clearance. Among diabetic individuals, per 0.1 mEq/l higher Mg, the odds of having TAC score >0 was higher (OR: 1.57; 95% CI: 1.09-2.26; P = 0.02). Mg was not associated with CAC or high ABI among diabetic individuals. Mg was not associated with PWV or pulse pressure regardless of diabetes status. CONCLUSION: Diabetes modified the associations of serum Mg with arterial calcification and stiffness in incident HD patients. Higher Mg was associated with less arterial calcification and less peripheral arterial stiffness among nondiabetic individuals, but Mg was only associated with TAC among diabetic individuals with higher Mg being associated with higher likelihood of having TAC score >0.
引用
- Chen W, Fitzpatrick J, Monroy-Trujillo JM, et al. Diabetes Mellitus Modifies the Associations of Serum Magnesium Concentration With Arterial Calcification and Stiffness in Incident Hemodialysis Patients. Kidney Int Rep. 2019. PMID: 31194171. doi:10.1016/j.ekir.2019.03.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。